Emerging PET/CT Radiopharmaceutical May Double Liver Foci Detection

An emerging PET/CT radiopharmaceutical may double the detection of liver foci in patients with neuroendocrine tumors.

Automated summary

RadPigeon summaries are original and for information only. They are not clinical advice.